| Primary |
| Diabetes Mellitus |
37.8% |
| Type 2 Diabetes Mellitus |
22.1% |
| Hypertension |
9.9% |
| Nephrotic Syndrome |
4.7% |
| Gastroenteritis |
3.5% |
| Gastritis |
2.3% |
| Renal Failure Chronic |
2.3% |
| Anaemia |
1.7% |
| Bipolar Disorder |
1.7% |
| Cerebral Infarction |
1.7% |
| Hyperlipidaemia |
1.7% |
| Hyperuricaemia |
1.7% |
| Multiple Sclerosis |
1.7% |
| Sciatica |
1.7% |
| Hepatic Cirrhosis |
1.2% |
| Hyperglycaemia |
1.2% |
| Product Used For Unknown Indication |
1.2% |
| Acute Pyelonephritis |
0.6% |
| Angina Pectoris |
0.6% |
| Chronic Hepatitis |
0.6% |
|
| Liver Disorder |
21.3% |
| Hepatic Function Abnormal |
19.4% |
| Pneumatosis Intestinalis |
12.0% |
| Hypoglycaemia |
7.4% |
| Ileus |
6.5% |
| Renal Impairment |
3.7% |
| Alanine Aminotransferase Increased |
2.8% |
| Hyperglycaemia |
2.8% |
| Hyperkalaemia |
2.8% |
| Oedema |
2.8% |
| Urine Output Decreased |
2.8% |
| Face Oedema |
1.9% |
| Haematochezia |
1.9% |
| Loss Of Consciousness |
1.9% |
| Multiple Sclerosis Relapse |
1.9% |
| Rectal Haemorrhage |
1.9% |
| Swelling Face |
1.9% |
| Thirst |
1.9% |
| Vomiting |
1.9% |
| Agranulocytosis |
0.9% |
|
| Secondary |
| Diabetes Mellitus |
18.0% |
| Type 2 Diabetes Mellitus |
16.9% |
| Drug Use For Unknown Indication |
14.6% |
| Hypertension |
11.8% |
| Nephrotic Syndrome |
4.5% |
| Pharyngitis |
4.5% |
| Arteriosclerosis |
3.4% |
| Cardiac Failure |
2.8% |
| Drug Hypersensitivity |
2.8% |
| Gastroenteritis |
2.8% |
| Gastritis |
2.2% |
| Hyperlipidaemia |
2.2% |
| Idiopathic Thrombocytopenic Purpura |
2.2% |
| Type 1 Diabetes Mellitus |
2.2% |
| Diabetic Retinopathy |
1.7% |
| Hyperuricaemia |
1.7% |
| Sciatica |
1.7% |
| Spinal Column Stenosis |
1.7% |
| Angina Pectoris |
1.1% |
| Breast Cancer |
1.1% |
|
| Thirst |
11.8% |
| Hepatic Function Abnormal |
9.8% |
| Diarrhoea |
7.8% |
| Ileus |
7.8% |
| Thrombocytopenia |
7.8% |
| Alanine Aminotransferase Increased |
5.9% |
| Hypoglycaemia |
5.9% |
| Lymphoma |
5.9% |
| Vomiting |
5.9% |
| Death |
3.9% |
| Intestinal Obstruction |
3.9% |
| Liver Disorder |
3.9% |
| Pneumatosis Intestinalis |
3.9% |
| Renal Impairment |
3.9% |
| Aspartate Aminotransferase Increased |
2.0% |
| Colitis |
2.0% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.0% |
| Drug-induced Liver Injury |
2.0% |
| Dyspnoea |
2.0% |
| Gastric Cancer |
2.0% |
|
| Concomitant |
| Diabetes Mellitus |
24.7% |
| Hypertension |
14.9% |
| Type 2 Diabetes Mellitus |
12.7% |
| Chronic Hepatitis C |
6.9% |
| Prophylaxis |
6.5% |
| Hepatitis C |
6.1% |
| Rheumatoid Arthritis |
5.4% |
| Product Used For Unknown Indication |
3.5% |
| Metastatic Renal Cell Carcinoma |
2.7% |
| Multiple Myeloma |
2.4% |
| Gastritis |
2.2% |
| Constipation |
2.0% |
| Dyslipidaemia |
1.8% |
| Hyperlipidaemia |
1.5% |
| Hyperuricaemia |
1.4% |
| Osteoporosis |
1.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.1% |
| Cataract |
1.0% |
| Asthma |
1.0% |
| Back Pain |
1.0% |
|
| White Blood Cell Count Decreased |
10.1% |
| Neutropenia |
8.3% |
| Drug Eruption |
6.4% |
| Interstitial Lung Disease |
6.4% |
| Renal Impairment |
6.4% |
| Hypoglycaemia |
5.5% |
| Pancreatic Carcinoma |
5.5% |
| Blood Creatinine Increased |
4.6% |
| Glycosylated Haemoglobin Increased |
4.6% |
| Osteomyelitis |
4.6% |
| Pyrexia |
4.6% |
| Diarrhoea |
3.7% |
| Fall |
3.7% |
| Hepatic Function Abnormal |
3.7% |
| Iron Deficiency Anaemia |
3.7% |
| Lymphangiosis Carcinomatosa |
3.7% |
| Lymphoma |
3.7% |
| Myalgia |
3.7% |
| Prostatitis |
3.7% |
| Rash |
3.7% |
|
